Amphastar Pharmaceuticals Inc vs DENTSPLY SIRONA Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.31B). The key difference: DENTSPLY SIRONA Inc is far larger — about 2.7× Amphastar Pharmaceuticals Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | XRAY | |
|---|---|---|
Market Cap | $868.62M | $2.31B |
Sector | Health | Health |
52-Week High | $30.81 | $14.68 |
52-Week Low | $16.87 | $9.64 |
Enterprise Value | $1.27B | $4.39B |
Dividend Yield | — | 5.04% |
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →